A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT02998840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 132 participants
- Sponsor
- AOBiome LLC
- Registry
-
NCT02998840
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02998840. Randomized; double masking; primary purpose treatment. Start 2016-11 (actual); primary completion 2017-04-25 (actual). Results posted on 2022-08-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
- Condition
- Prehypertension
- Condition
- Hypertension, Stage I
- Intervention (Biological)
- B244
- Intervention (Biological)
- Vehicle
- Lead sponsor
- AOBiome LLC
- Collaborator
- Veristat, Inc.
Record details
- Record id
cardio:ct-nct02998840- Content hash
a90544208db956e5ac39f11c8cb955b263554ff5c2ead093dbe7479d64ac115c